🇺🇸 FDA
Patent

US 7947720

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7947720 (3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands) held by Pharmacopeia Drug Discovery, Inc. expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18